REGN Directional Report
Analysis based on market close March 31, 2026
Outlook
Neutral-to-bullish with a multi-week pinning bias toward the $745-$760 max pain cluster. Confidence: 7.5/10. Spot is 3.7% above nearest max pain, but positive GEX and DEX create a strong magnet lower, while structural call buying in the $600s provides a bullish tailwind.
Conflicts: Spot ($772.64) is above all near-term max pain levels ($745-$760), creating a gravitational pull lower that conflicts with bullish flow.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $+465K
DEX: +999K shares
Gamma flip: ~$730 (Approx โ based on put OI concentration of 1,193)
NTM gamma: Positive GEX implies dealers will sell into rallies and buy into dips to hedge, reinforcing the range. A move below the ~$730 gamma flip would see hedging flip to accelerate selling.
IV Analysis
IV vs VIX: IV 44.2% is high in absolute terms, favoring premium sellers, especially in a pinning regime.
Term structure: Humped with a kink: 2-day IV 46.1% > 10-day 36.9% < 31-day 49.3%. The elevated IV for the 4/29 earnings expiry (5/01, 49.3%) creates a calendar spread opportunity.
Skew: The ~12.4 vol-point differential between 5/01 (49.3%) and 4/17 (39.4%) expirations supports a reverse calendar (sell high IV far, buy lower IV near).
Flow Analysis
Net premium: +$4.9M bullish; P/C vol 0.84, P/C OI 0.97 indicate balanced but slightly call-leaning activity.
Directional prints: 1) $1000/$1020 Puts saw ~$3.2M net premium โ likely sold puts (bullish) or bought for protection. 2) $550-$680 Calls saw ~$3M net premium โ likely bought calls (bullish positioning). Given net premium positive, bought calls is the more consistent interpretation.
Unusual: Massive OTM put sales at $1000/$1020 and call buys at $550-$680 represent structural, longer-dated positioning, not near-term speculation.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long stock | Moderate | Buy shares at ~$772.5. Use a stop below $730. | Immediate max pain gravity pull to $745-$760. |
| Short stock | Weak | N/A โ avoid against positive GEX and bullish flow. | Dealer pinning support and structural call buying provide strong bids. |
| Covered call | Moderate-Strong | Own stock, sell $780C or $790C for 4/10 or 4/17 expiry. | Stock drifts to max pain below strike, capping upside. |
| Cash-secured put / put spread | Moderate-Strong | Sell $730/$725 put spread 4/17 (below key support). | Break below $730 invalidates thesis. |
| Long calls | Moderate-Weak | Buy $760C or $770C 4/17, but high IV and pinning are headwinds. | Vol crush and max pain gravity. |
| Long puts / bear put spread | Moderate | Buy $760/$750 put spread 4/10, betting on drift to max pain. | Positive GEX dampens downward momentum. |
| Iron condor | Moderate-Strong | $750P/$740P x $790C/$800C 4/17. GEX positive and VIX context unknown, but pinning supports. | Break outside $740-$790 range. |
| Calendar/diagonal | Moderate | Reverse Calendar: Sell $760C 5/01 (IV 49.3%), Buy $760C 4/17 (IV 39.4%). | Earnings volatility shift. |
| PMCC / LEAPS diagonal | Moderate-Strong | Buy $600C Jan 2027 (~$180), sell $780C against it monthly. | Capital intensive; stock stagnation. |
Top Plays
Watchlist Triggers
Tactical Summary
Read the Directional analysis for REGN. This AI-generated report covers regime classification, key price levels, strategy recommendations, and actionable trade ideas drawn from end-of-day options data including gamma exposure, delta exposure, and implied volatility.